HNB
RDY icon

Huntington National Bank’s Dr. Reddy's Laboratories RDY Stock Holding History

Huntington National Bank’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14 Hold
1
– – ﹤0.01% 3644
2025
Q4 		$14 Hold
1
– – ﹤0.01% 3556
2025
Q3 		$14 Hold
1
– – ﹤0.01% 3592
2025
Q2 		$15 Hold
1
– – ﹤0.01% 3576
2025
Q1 		$13 Sell
1
-84
-99% -$1.16K ﹤0.01% 3652
2024
Q4 		$1.34K Sell
85
-25
-23% -$376 ﹤0.01% 2334
2024
Q3 		$1.75K Hold
110
– – ﹤0.01% 2267
2024
Q2 		$1.68K Buy
110
+105
+2,100% +$1.5K ﹤0.01% 2210
2024
Q1 		$73 Sell
5
-470
-99% -$6.86K ﹤0.01% 2602
2023
Q4 		$6.61K Buy
475
+5
+1% +$67 ﹤0.01% 1788
2023
Q3 		$6.29K Sell
470
-20
-4% -$271 ﹤0.01% 1728
2023
Q2 		$6.18K Buy
490
+10
+2% +$117 ﹤0.01% 1732
2023
Q1 		$5.46K Hold
480
– – ﹤0.01% 1710
2022
Q4 		$4.97K Buy
480
+230
+92% +$2.48K ﹤0.01% 1646
2022
Q3 		$3K Sell
250
-160
-39% -$1.7K ﹤0.01% 1803
2022
Q2 		$5K Buy
410
+15
+4% +$163 ﹤0.01% 1737
2022
Q1 		$4K Sell
395
-30
-7% -$340 ﹤0.01% 1806
2021
Q4 		$6K Buy
+425
New +$5.36K ﹤0.01% 1700
2016
Q2 		– Sell
-22,330
Closed -$255K – 1634
2016
Q1 		$255K Buy
22,330
+9,705
+77% +$86.7K 0.01% 576
2015
Q4 		$117K Sell
12,625
-5,505
-30% -$60.3K ﹤0.01% 771
2015
Q3 		$232K Sell
18,130
-4,055
-18% -$50.4K 0.01% 579
2015
Q2 		$245K Sell
22,185
-145
-0.6% -$1.6K 0.01% 604
2015
Q1 		$255K Buy
22,330
+560
+3% +$5.94K 0.01% 577
2014
Q4 		$220K Buy
+21,770
New +$229K 0.01% 634

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Huntington National Bank's RDY Position: Q1 2026 in Review

Huntington National Bank held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3644.

Huntington National Bank first reported a position in RDY in Q4 2014 and has held it in 24 quarters since. The position peaked at $255K in Q1 2016. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Huntington National Bank held 1 share of Dr. Reddy's Laboratories worth $14 as of Q1 2026.
  • Huntington National Bank left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3644 holding.
  • Huntington National Bank first reported a position in Dr. Reddy's Laboratories in Q4 2014 and has held it in 24 quarters since.
  • Huntington National Bank's Dr. Reddy's Laboratories position peaked at $255K in Q1 2016.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.